NASDAQ:RCM R1 RCM (RCM) Stock Price, News & Analysis → My next big prediction isn’t a prediction (From Porter & Company) (Ad) Free RCM Stock Alerts $13.17 -0.35 (-2.59%) (As of 03/18/2024 ET) Add Compare Share Share Today's Range$13.16▼$13.5250-Day Range$9.11▼$14.5852-Week Range$8.87▼$18.70Volume1.84 million shsAverage Volume4.35 million shsMarket Capitalization$5.54 billionP/E RatioN/ADividend YieldN/APrice Target$17.41 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get R1 RCM alerts: Email Address R1 RCM MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside32.2% Upside$17.41 Price TargetShort InterestHealthy11.67% of Float Sold ShortDividend StrengthN/ASustainability-1.33Upright™ Environmental ScoreNews Sentiment0.86Based on 9 Articles This WeekInsider TradingSelling Shares$143,959 Sold Last QuarterProj. Earnings GrowthGrowingFrom ($0.04) to $0.15 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.92 out of 5 starsBusiness Services Sector4th out of 311 stocksManagement Services Industry1st out of 5 stocks 4.4 Analyst's Opinion Consensus RatingR1 RCM has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 12 buy ratings, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $17.41, R1 RCM has a forecasted upside of 32.2% from its current price of $13.17.Amount of Analyst CoverageR1 RCM has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 4.0 Short Interest Percentage of Shares Shorted11.67% of the float of R1 RCM has been sold short.Short Interest Ratio / Days to CoverR1 RCM has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in R1 RCM has recently decreased by 39.54%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldR1 RCM does not currently pay a dividend.Dividend GrowthR1 RCM does not have a long track record of dividend growth. Previous Next 3.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreR1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.Environmental SustainabilityThe Environmental Impact score for R1 RCM is -1.33. Previous Next 3.8 News and Social Media Coverage News SentimentR1 RCM has a news sentiment score of 0.86. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 9 news articles for R1 RCM this week, compared to 5 articles on an average week.Search Interest14 people have searched for RCM on MarketBeat in the last 30 days. This is an increase of 367% compared to the previous 30 days.MarketBeat Follows14 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is an increase of 56% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, R1 RCM insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $143,959.00 in company stock.Percentage Held by Insiders37.00% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions61.10% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for R1 RCM are expected to grow in the coming year, from ($0.04) to $0.15 per share.Price to Book Value per Share RatioR1 RCM has a P/B Ratio of 2.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceThey said crypto was dead. It went up 100X.Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away. About R1 RCM Stock (NASDAQ:RCM)R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.Read More RCM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RCM Stock News HeadlinesMarch 11, 2024 | insidertrades.comR1 RCM Inc. (NASDAQ:RCM) President Sells $143,959.18 in StockMarch 16, 2024 | americanbankingnews.comR1 RCM Inc. (NASDAQ:RCM) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMarch 19, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.March 15, 2024 | finance.yahoo.comRCM Apr 2024 20.000 callMarch 13, 2024 | americanbankingnews.comR1 RCM Inc. (NASDAQ:RCM) Short Interest Down 39.5% in FebruaryMarch 12, 2024 | markets.businessinsider.comHold Rating on R1 RCM Amid Acquisition Talks and Valuation ConsiderationsMarch 11, 2024 | markets.businessinsider.comR1 RCM Announces Formation Of Special Committee To Evaluate Strategic AlternativesMarch 11, 2024 | msn.comR1 RCM forms special committee to evaluate options after New Mountain's offerMarch 19, 2024 | Behind the Markets (Ad)The only AI company you should be looking atThis is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.March 11, 2024 | markets.businessinsider.comR1 RCM Poised for Growth: Outperform Rating and $17 Target Justified by Strong LBO Potential and Historical MultiplesMarch 11, 2024 | marketwatch.comR1 RCM to Explore Strategic Options After New Mountain ApproachMarch 11, 2024 | finance.yahoo.comR1 RCM Forms Special Committee to Evaluate Strategic AlternativesMarch 11, 2024 | americanbankingnews.comResearch Analysts Set Expectations for R1 RCM Inc.'s Q1 2024 Earnings (NASDAQ:RCM)March 9, 2024 | americanbankingnews.comR1 RCM (NASDAQ:RCM) Rating Reiterated by Royal Bank of CanadaMarch 9, 2024 | americanbankingnews.comLeerink Partnrs Weighs in on R1 RCM Inc.'s Q2 2024 Earnings (NASDAQ:RCM)March 6, 2024 | msn.comTruist Securities Downgrades R1 RCM (RCM)March 5, 2024 | msn.comR1 RCM slips after cut to hold at Truist on limited upside in takeoverMarch 5, 2024 | markets.businessinsider.comMaintaining Hold on R1 RCM Amid Acquisition Proposal and Mixed Financial OutlookMarch 3, 2024 | seekingalpha.comVoss Capital - R1 RCM Inc.: Bull Case Achievable Despite Negative SentimentMarch 1, 2024 | uk.investing.comR1 RCM downgraded at Citi, 'likely' acquired for a higher priceMarch 1, 2024 | realmoney.thestreet.comR1 RCM just downgraded at Citi, here's whyMarch 1, 2024 | markets.businessinsider.comBuy Rating Affirmed on R1 RCM Amid Strong Q4 Performance and Pragmatic FY2024 OutlookMarch 1, 2024 | businesswire.comR1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsFebruary 29, 2024 | msn.comR1 RCM dips as Citi downgrades to neutral after New Mountain bidFebruary 29, 2024 | finance.yahoo.comR1 RCM Inc. (RCM) Reports Notable Revenue and EBITDA Growth in Q4 and Full Year 2023February 29, 2024 | finance.yahoo.comWhat Makes R1 RCM (RCM) a Lucrative Investment?February 28, 2024 | markets.businessinsider.comTD Cowen Keeps Their Buy Rating on R1 RCM (RCM)See More Headlines Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/16/2023Today3/18/2024Next Earnings (Estimated)5/02/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Management services Sub-IndustryHealth Care Services Current SymbolNASDAQ:RCM Previous SymbolNYSE:RCM CUSIP00438V10 CIK1472595 Webwww.r1rcm.com Phone(312) 324-7820Fax302-655-5049Employees30,000Year Founded2003Price Target and Rating Average Stock Price Target$17.41 High Stock Price Target$22.00 Low Stock Price Target$11.00 Potential Upside/Downside+32.2%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage16 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$3.30 million Net Margins0.15% Pretax Margin0.93% Return on Equity0.12% Return on Assets0.07% Debt Debt-to-Equity Ratio0.57 Current Ratio1.83 Quick Ratio1.83 Sales & Book Value Annual Sales$2.25 billion Price / Sales2.46 Cash Flow$0.66 per share Price / Cash Flow19.95 Book Value$6.56 per share Price / Book2.01Miscellaneous Outstanding Shares420,280,000Free Float264,776,000Market Cap$5.54 billion OptionableOptionable Beta0.79 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Lee Rivas (Age 49)CEO & Director Comp: $1.12MMr. John M. Sparby (Age 48)President Comp: $656.99kMs. Jennifer Williams (Age 47)Executive VP, CFO & Treasurer Ms. Pamela L. Spikner (Age 47)Principal Accounting Officer & Chief Accounting Officer Evan Smith C.F.A.Senior Vice President of Finance & Investor RelationsMr. Corey PermanExecutive Vice President of Compliance & RiskMr. Sean RadcliffeExecutive VP, General Counsel & Corporate SecretaryMs. Kate SandersonExecutive VP & Chief Human Resources OfficerMr. David StrickleExecutive Vice President of IntegrationMr. Kyle A. Hicok (Age 44)Executive VP & Chief Commercial Officer More ExecutivesKey CompetitorsGenpactNYSE:GTriNet GroupNYSE:TNETMarathon DigitalNASDAQ:MARAFirstCashNASDAQ:FCFSExlServiceNASDAQ:EXLSView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Sold 2,744,298 shares on 3/11/2024Ownership: 3.616%John M SparbySold 10,046 sharesTotal: $143,959.18 ($14.33/share)American International Group Inc.Sold 11,437 shares on 2/28/2024Ownership: 0.063%Teachers Retirement System of The State of KentuckyBought 20,000 shares on 2/26/2024Ownership: 0.016%Eventide Asset Management LLCBought 640,275 shares on 2/20/2024Ownership: 0.328%View All Insider TransactionsView All Institutional Transactions RCM Stock Analysis - Frequently Asked Questions Should I buy or sell R1 RCM stock right now? 16 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 4 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" RCM shares. View RCM analyst ratings or view top-rated stocks. What is R1 RCM's stock price target for 2024? 16 Wall Street analysts have issued twelve-month price targets for R1 RCM's stock. Their RCM share price targets range from $11.00 to $22.00. On average, they expect the company's share price to reach $17.41 in the next twelve months. This suggests a possible upside of 32.2% from the stock's current price. View analysts price targets for RCM or view top-rated stocks among Wall Street analysts. How have RCM shares performed in 2024? R1 RCM's stock was trading at $10.57 at the beginning of the year. Since then, RCM shares have increased by 24.6% and is now trading at $13.17. View the best growth stocks for 2024 here. Are investors shorting R1 RCM? R1 RCM saw a decline in short interest during the month of February. As of February 29th, there was short interest totaling 17,490,000 shares, a decline of 39.5% from the February 14th total of 28,930,000 shares. Based on an average daily trading volume, of 4,700,000 shares, the days-to-cover ratio is presently 3.7 days. Currently, 11.7% of the company's shares are sold short. View R1 RCM's Short Interest. When is R1 RCM's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024. View our RCM earnings forecast. How were R1 RCM's earnings last quarter? R1 RCM Inc. (NASDAQ:RCM) announced its quarterly earnings data on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share for the quarter, missing the consensus estimate of ($0.03) by $0.06. The healthcare provider earned $532.80 million during the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a trailing twelve-month return on equity of 0.12% and a net margin of 0.15%. The business's quarterly revenue was up 33.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.11 EPS. What ETFs hold R1 RCM's stock? ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Thrivent Small-Mid Cap ESG ETF (TSME), Fidelity Digital Health ETF (FDHT) and SPDR S&P Health Care Services ETF (XHS).iShares U.S. Healthcare Providers ETF (IHF). What guidance has R1 RCM issued on next quarter's earnings? R1 RCM issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $2.6 billion-$2.7 billion, compared to the consensus revenue estimate of $2.7 billion. What is Joseph Flanagan's approval rating as R1 RCM's CEO? 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees. What other stocks do shareholders of R1 RCM own? Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN). Who are R1 RCM's major shareholders? R1 RCM's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.62%), Vanguard Group Inc. (3.62%), Capital International Investors (1.99%), Voss Capital LLC (1.70%), Norges Bank (0.96%) and P2 Capital Partners LLC (0.84%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John B Henneman III, John M Sparby, Joseph Gerard Flanagan, Lee Rivas and Richard B Jr Evans. View institutional ownership trends. How do I buy shares of R1 RCM? Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Does R1 RCM have any subsidiaries? The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.Read More This page (NASDAQ:RCM) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressAltcoin FRENZY Alert…Crypto 101 MediaThe AI Bottleneck No One is Talking AboutThe Bull ReportMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceSHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding R1 RCM Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.